- Home
- INMB vs ACR Comparison
INMB vs ACR Comparison
Compare INMB & ACR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INMB
- ACR
- Stock Information
- Founded
- INMB 2015
- ACR 2005
- Country
- INMB United States
- ACR United States
- Employees
- INMB N/A
- ACR N/A
- Industry
- INMB Biotechnology: Pharmaceutical Preparations
- ACR Real Estate Investment Trusts
- Sector
- INMB Health Care
- ACR Real Estate
- Exchange
- INMB Nasdaq
- ACR Nasdaq
- Market Cap
- INMB 123.0M
- ACR 121.1M
- IPO Year
- INMB 2019
- ACR N/A
- Fundamental
- Price
- INMB $5.30
- ACR $15.83
- Analyst Decision
- INMB Buy
- ACR Buy
- Analyst Count
- INMB 1
- ACR 1
- Target Price
- INMB $22.00
- ACR $17.50
- AVG Volume (30 Days)
- INMB 358.3K
- ACR 17.4K
- Earning Date
- INMB 10-30-2024
- ACR 10-30-2024
- Dividend Yield
- INMB N/A
- ACR N/A
- EPS Growth
- INMB N/A
- ACR N/A
- EPS
- INMB N/A
- ACR 0.82
- Revenue
- INMB $85,000.00
- ACR $76,816,000.00
- Revenue This Year
- INMB N/A
- ACR N/A
- Revenue Next Year
- INMB N/A
- ACR $1.76
- P/E Ratio
- INMB N/A
- ACR $19.22
- Revenue Growth
- INMB N/A
- ACR 13.82
- 52 Week Low
- INMB $4.81
- ACR $6.62
- 52 Week High
- INMB $14.74
- ACR $16.13
- Technical
- Relative Strength Index (RSI)
- INMB 40.85
- ACR 58.70
- Support Level
- INMB $5.09
- ACR $15.65
- Resistance Level
- INMB $5.73
- ACR $15.87
- Average True Range (ATR)
- INMB 0.32
- ACR 0.25
- MACD
- INMB 0.08
- ACR -0.00
- Stochastic Oscillator
- INMB 52.41
- ACR 77.46
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.
About ACR ACRES Commercial Realty Corp.
ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.